Catalyst Pharmaceuticals Inc (CPRX)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	163,889	71,410	83,079	39,482	74,983
Revenue	US$ in thousands	491,734	398,204	214,203	140,833	119,073
Net profit margin		33.33%	17.93%	38.79%	28.03%	62.97%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $163,889K ÷ $491,734K
= 33.33%

The net profit margin of Catalyst Pharmaceuticals Inc has shown fluctuations over the past five years. In December 2020, the net profit margin was high at 62.97%, indicating that the company was able to convert a significant portion of its revenue into profit. However, by December 2021, the net profit margin had decreased to 28.03%, suggesting a decline in profitability.

In the following years, there was some improvement as the net profit margin increased to 38.79% by December 2022. However, by December 2023, the net profit margin dropped to 17.93%, indicating a significant decrease in profitability.

The most recent data point, December 31, 2024, shows a net profit margin of 33.33%, which represents a partial recovery from the previous year but is still below the levels seen in 2020 and 2022.

Overall, the trend in the net profit margin of Catalyst Pharmaceuticals Inc indicates both periods of strong profitability and challenges in maintaining consistent margins over the five-year period.